Carlos O Garrido1, Rebekah A Coşkun2, Adrienne B Lent2, Elizabeth Calhoun2, Robin B Harris2. 1. Arizona Cancer Center, University of Arizona, 1515 N Campbell Ave, Tucson, AZ, 85719, USA. carlosgarrido@email.arizona.edu. 2. Arizona Cancer Center, University of Arizona, 1515 N Campbell Ave, Tucson, AZ, 85719, USA.
Abstract
PURPOSE: The 2010 Affordable Care Act (ACA) provided millions of people with health insurance coverage and facilitated routine cancer screening by requiring insurers to cover preventive services without cost-sharing. Despite greater access to affordable cancer screening, Pap testing has declined over time. The aim of this study is to assess participation in Pap test and HPV vaccination, and adherence to guidelines as outlined by the American Cancer Society (ACS) from the 2010 ACA provision eliminating cost-sharing for preventive services. METHODS: Using multi-year responses from the Behavioral Risk Factor Surveillance System, we examined the association between the ACA and participation in and adherence to Pap testing and HPV vaccination behaviors as set by the ACS. The sample included women aged 21-29 who completed the survey between 2008 and 2018 (every other year) and who live in 24 US States (N = 37,893). RESULTS: Results showed significant decreases in Pap testing rates but increases in the uptake of the HPV vaccine series for all age groups and across all demographics. Post-ACA year significantly predicted increases in HPV + Pap co-testing participation and adherence. Women with health insurance coverage were more likely to engage in both behaviors. CONCLUSION: Findings raise concerns around declines in the proportion of women receiving and adhering to Pap testing guidelines. A need exists for research to examine the role of increases in HPV vaccination uptake on decreases in Pap testing. Moreover, effective strategies should target increases in cervical cancer screening uptake among women vaccinated against HPV.
PURPOSE: The 2010 Affordable Care Act (ACA) provided millions of people with health insurance coverage and facilitated routine cancer screening by requiring insurers to cover preventive services without cost-sharing. Despite greater access to affordable cancer screening, Pap testing has declined over time. The aim of this study is to assess participation in Pap test and HPV vaccination, and adherence to guidelines as outlined by the American Cancer Society (ACS) from the 2010 ACA provision eliminating cost-sharing for preventive services. METHODS: Using multi-year responses from the Behavioral Risk Factor Surveillance System, we examined the association between the ACA and participation in and adherence to Pap testing and HPV vaccination behaviors as set by the ACS. The sample included women aged 21-29 who completed the survey between 2008 and 2018 (every other year) and who live in 24 US States (N = 37,893). RESULTS: Results showed significant decreases in Pap testing rates but increases in the uptake of the HPV vaccine series for all age groups and across all demographics. Post-ACA year significantly predicted increases in HPV + Pap co-testing participation and adherence. Women with health insurance coverage were more likely to engage in both behaviors. CONCLUSION: Findings raise concerns around declines in the proportion of women receiving and adhering to Pap testing guidelines. A need exists for research to examine the role of increases in HPV vaccination uptake on decreases in Pap testing. Moreover, effective strategies should target increases in cervical cancer screening uptake among women vaccinated against HPV.
Entities:
Keywords:
Affordable care act; Cancer screening; Cervical cancer; Cost-sharing; Human papilloma virus
Authors: Héctor E Alcalá; Jie Chen; Brent A Langellier; Dylan H Roby; Alexander N Ortega Journal: J Am Board Fam Med Date: 2017-01-02 Impact factor: 2.657
Authors: Kathleen Conroy; Susan L Rosenthal; Gregory D Zimet; Yan Jin; David I Bernstein; Susan Glynn; Jessica A Kahn Journal: J Womens Health (Larchmt) Date: 2009-10 Impact factor: 2.681
Authors: Gregory D Zimet; Thomas W Weiss; Susan L Rosenthal; Margaret B Good; Michelle D Vichnin Journal: BMC Womens Health Date: 2010-09-01 Impact factor: 2.809
Authors: Ingrid J Hall; Florence K L Tangka; Susan A Sabatino; Trevor D Thompson; Barry I Graubard; Nancy Breen Journal: Prev Chronic Dis Date: 2018-07-26 Impact factor: 2.830
Authors: Jennifer C Spencer; Noel T Brewer; Tamera Coyne-Beasley; Justin G Trogdon; Morris Weinberger; Stephanie B Wheeler Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-09-09 Impact factor: 4.254
Authors: Caitlin B Biddell; Lisa P Spees; Jennifer S Smith; Noel T Brewer; Andrea C Des Marais; Busola O Sanusi; Michael G Hudgens; Lynn Barclay; Sarah Jackson; Erin E Kent; Stephanie B Wheeler Journal: J Womens Health (Larchmt) Date: 2021-04-13 Impact factor: 3.017